Business

Viatris Appoints Matthew J. Maletta as Chief Legal Officer

Viatris Inc. (Nasdaq: VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 20

articleViatris Inc.February 3, 20265/company/viatris-inc/news/viatris-appoints-matthew-j-maletta-133000269
Viatris Appoints Matthew J. Maletta as Chief Legal Officer

About this update from Viatris Inc.

[{"type":"text","content":"Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period ","length":125,"tagName":"p","attribs":{}},{"type":"text","content":"PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 2026, to ensure a smooth transition.","length":588,"tagName":"p"},{"type":"image","alt":"Viatris announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026.","displaySize":"","headline":null,"caption":"Viatris announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/780f1577d70d57685377e11c968f3227"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/5cYWXa2pZMjJM6RfKL6WZg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/780f1577d70d57685377e11c968f3227","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2875194/Viatris_Matthew_J_Maletta.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Maletta is an accomplished public company executive, with nearly 30 years of legal experience and deep expertise in leading legal teams for both generic and branded pharmaceutical companies. From 2015 to 2025, he served as Executive Vice President, Chief Legal Officer and Corporate Secretary at Endo, where he oversaw Endo's merger with Mallinckrodt and the subsequent spin-off of Par Health.","length":397,"tagName":"p"},{"type":"text","content":"Prior to that, he served for over a decade in the legal department at Allergan, rising to Vice President, Associate General Counsel and Corporate Secretary. His experience at Allergan included serving as lead attorney for all business ...

More updates from Viatris Inc.

Brian RomanViatrisMatthew J. MalettaMalettaChief Legal Officerlegal experienceCorporate Secretarybusiness development experiencepharmaceutical companiesScott A. Smith